Riskpilot← Back to searchSign inGet full accessOctean AB
ABActiveOrg 5562712728Norra Torggatan 15Manufacture of pharmaceutical preparations · NACE 2120Est. 19865-9 employees
Revenue 2024
SEK -188K
-100% vs 2023
EBITDA margin
100.0%
-100% vs 2023
Equity ratio
37.0%
Financial strength
Net profit 2024
SEK 231K
-70% vs 2023
| Revenue | SEK -188K | -100% |
| EBITDA | SEK -188K | -100% |
| Net profit | SEK 231K | -70% |
| Total assets | SEK 17,6M | -3% |
| Equity | SEK 6,5M | -11% |
| Employees | — | — |
Legal name
Octean AB
Org number
5562712728
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
16 januari 1986
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva partihandel med hälsokostprodukter, natur- medel, naturläkemedel, medicinsk utrustning och apoteksvaror. Bolaget skall vidare bedriva handel inom detta produktområde mot terapeuter och mot allmänheten. Bolaget skall också bedriva förvaltning av aktier och andra värdepapper samt därmed förenlig verksamhet.
Address
Norra Torggatan 15
Email
hanna@octean.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 53 199 | 53 118 | 51 415 | 54 236 | −188 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 650 | 2 426 | 1 188 | 54 236 | −188 |
| Depreciation & amort. | — | — | — | −7 | −7 |
| EBIT | 3 650 | 2 426 | 1 188 | 798 | −195 |
| Net financials | −6 | −2 | −19 | −153 | 60 |
| Profit before tax | 3 523 | 2 499 | 1 468 | — | — |
| Tax | −782 | −538 | −328 | −281 | −95 |
| Net profit | 2 741 | 1 961 | 1 140 | 763 | 231 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 855 | 20 252 | 18 133 | 18 215 | 17 641 |
| Equity | 7 923 | 7 884 | 8 025 | 7 288 | 6 519 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 7 639 | 8 150 | 6 190 | — | — |
| Total debt | 7 639 | 8 150 | 6 190 | — | — |
EBITDA margin
-18822600.0%
This company
15.8%
Market median
-119130480% vs market
20202024
Equity ratio
37.0%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
3.5%
This company
18.4%
Market median
-81% vs market
20202024
Net profit margin
23062700.0%
This company
8.1%
Market median
+284724591% vs market
20202024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20202024
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MF Chief Auditor | Chief Auditor | 2022 |
HM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Halobid Aktiebolag
Octean AB Board members of Octean AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Fjellman | Chief Auditor | 0 companies |
| Hanna Magnusson | Chief Executive Officer | 0 companies |
| Dan Åke Magnusson | Deputy Board Member | 0 companies |
| Lotte Johannesson | Chairman | 0 companies |